What are the recommendations for aspirin use in primary prevention of ASCVD?
It is recommended that low-dose aspirin (75-100 mg orally daily) might be considered for the primary prevention of ASCVD among select adults 40 to 70 years of age who are at higher ASCVD risk but not at increased bleeding. However, it should not be administered on a routine basis for the primary prevention of ASCVD among adults >70 years of age, or among adults of any age who are at increased risk of bleeding.